
October 2007
Printer-friendly version
St. John’s Memory
Disorders Center treats multiple causes of dementia
By Thomas Habiger, M.D., medical director, St. John’s Memory Disorders
Center
Alzheimer’s
disease continues to have a major impact on health care. An estimated 5
million Americans have Alzheimer’s disease, but possibly only half have
been diagnosed.
Those
numbers over the next 40 years could reach 16 million individuals, which
will have a staggering impact on the ability to provide health care to
these individuals and Americans in general. The current estimate for
direct and indirect cost is $148 billion, with current Medicare spending
of $91 billion increasing to as much as $189 billion by 2015.
It is
an amazing testament to current research that only 25 years ago, the
actual protein makeup of the amyloid plaque (beta-amyloid) was identified.
In that time period, tremendous gains have been made in both the biology
and genetics of this disorder.
This
research has led to an array of various therapeutic targets, many of which
are approaching or completing human trials. Although some have failed,
there has been a number of new medications which are rapidly approaching
possible use over the next five years. Another major initiative has been
the attempt at identifying individuals at risk through the use of
biomarkers and neuroimaging. These have led to a number of very specific
tools that will also be clinically available to us in the next five to 10
years. All of this will dramatically change how we diagnose and treat
Alzheimer’s.
Probably the most useful tool in treating this disease has been identified
through epidemiological
studies. These studies have identified high-risk individuals who could
benefit from intensive lifestyle interventions. There is strong evidence
to aggressively control various vascular risk factors such as
hyperlipidemia, hypertension and diabetes, and limit alcohol, avoid
tobacco and eat a Mediterranean diet, which may markedly reduce the risk
of Alzheimer’s.
Early
diagnosis and intervention still has the ability to make a significant
impact. St. John’s Memory Disorders Clinic is approaching its 10th
year at St. John’s Senior Center. The clinic’s goal is to increase
awareness of dementia and aggressively treat dementia patients. As the
only clinic of its kind in the region, St. John’s Memory Disorders Clinic
includes the services of neurologists and a neuropsychologist.
Early
interventions help not only with quality of life for the patient, but also
the caregiver, and delay the onset of behavioral problems and the need for
long-term care.
When
a patient is referred to the Memory Disorders Clinic, a complete
neurological and medical evaluation is conducted in order to identify
causes of memory problems and find the most effective plan for each
individual patient. The evaluation may include laboratory testing, a brain
scan, a neuropsychological consultation, neuropsychometric testing, social
services, and referrals for physical therapy or occupational therapy.
A
referral for a sleep study may also be part of the evaluation to rule out
sleep disorders. A report, including recommendations for treatment, is
provided to the patient’s primary care physician after the evaluation.
Nonmedical treatments such as behavior management and memory aids are also
used.
We
look forward to helping referring physicians for patients and family needs
as we continue to improve diagnosis and treatment for memory-disorder
patients.
For more information
about St. John's Memory Disorders Center, or to referral a patient, please
call
417-820-2936 or visit our
Web site.
|